Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Bionor Pharma

- PMLiVE

GSK, J&J say monthly injection keeps HIV controlled

The once every four-week treatment could free those from taking daily pills

- PMLiVE

Streaming Well to “raise the bar in pharma film making”

Company appoints Steve Skinner and Freddie Slaughter to further its goal

Lighthouse Medical Communications US appoints Lisa Druce as its new Managing Partner

Lighthouse Medical Communications US, a Lucid Group company, is delighted to announce the appointment of its new Managing Partner, Lisa Druce.Lisa is an experienced strategic business leader and healthcare communications...

Lucid Group Communications Limited

- PMLiVE

FCB Health’s Neon attracts new managing director

Mardene Miller will lead the agency with co-managing director Kevin McHale

- PMLiVE

New faces at BioStrata, PSL Group and FCB Health

The latest movers in healthcare comms

Vaccines: Our experience and expertise

We have designed a complimentary infographic outlining the market opportunity as well as our experience and expertise in the area of vaccines. The infographic also includes links to a range of...

Research Partnership

- PMLiVE

New hires at Ferring, Flexion and Immunocore

The latest movers in pharma

- PMLiVE

New faces at Lucid, 90Ten and Page & Page

The latest movers in med comms

- PMLiVE

New hires at Nanoform, Leo Pharma and Calliditas

The latest movers in pharma and biotech

Lucid Group prepare for a transformative year with the appointment of a new Director of Corporate Development

Lucid Group is setting itself up for another stellar year with a new appointment to their senior leadership team. Rob Apollo has joined Lucid on a permanent basis as Director...

Lucid Group Communications Limited

- PMLiVE

McCann Health announces new global chief creative officer

Matt Eastwood joins the healthcare comms giant from J. Walter Thompson

- PMLiVE

MSD claims EU approval for two HIV products

Company battles back against dominant Gilead and GSK

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links